InvestorsHub Logo

The Canes

08/29/21 10:35 AM

#352721 RE: JBWIN #352715

Thanks for setting the record straight. The posters that get into piling on don't seem to be short the stock. They’re aggrieved, into conspiracy theories and incessantly venting due to imaginary frustrations. We may get knocked back down to $5 but KM is not to blame. Any one that thought Vascepa was going to become an anti-viral success was dreaming. Good things are on the horizon for the remainder of the year. I’ll be buying tomorrow on a dip.

rosemountbomber

08/29/21 10:51 AM

#352726 RE: JBWIN #352715

I also do not think KM was pumping either but he was quoted saying this:

“We are also looking forward to the first readout from PREPARE-IT 1, part of a larger investigator-initiated study program, looking at the potential benefits of VASCEPA/VAZKEPA for the prevention of COVID-19 in people at risk of exposure to the infection. With COVID-19 continuing to spread due to variants as well as low vaccine rates globally, these data could provide valuable insights in the ongoing fight against this pandemic.”


https://finance.yahoo.com/news/latest-clinical-research-evaluating-vascepa-110000569.html


I don’t see anything bad in his statement but I wish he would have qualified a bit by saying that he was also lookink foward to Prepare-It 2